NCT07636590ClinicalTrials.gov
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
A Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
En bref
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
Observationnelle500 participants recherchés21 sites1 pays
Catégories
Enregistré dans 1 registre
- ClinicalTrials.govNCT07636590Ouvrir cette fiche sur ClinicalTrials.govSynchronisé avant-hier
Une même étude peut être enregistrée dans plusieurs registres. Nous l'affichons une seule fois et renvoyons vers chaque fiche que nous détenons.
Les informations de l'essai sont affichées telles que publiées par le registre, dans leur langue d'origine.
Cette étude vous intéresse ?
Se connecter ou créez un compte pour manifester votre intérêt et suivre cette étude.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Not stated: Registered after enrolment began (about 18 days after the recorded start)First posted 2026-06-09; recorded start 2026-05-22
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Not stated: Whether participants are randomly assigned is not stated in the registry recordNo allocation method is recorded
- Not stated: A comparison group is not stated in the registry recordThe record describes a single study arm
- Not stated: Whether the study is blinded is not stated in the registry recordNo masking information is recorded
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 2 other studies in this databaseCounted from the lead sponsor named in the record (Claris Biotherapeutics, Inc.)
- Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation0/20
Allocation not stated in the record
- Blinding0/20
Masking not stated in the record
- Control arm0/15
No comparator arm stated in the record
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre5/8
Multi-centre: 2 sites
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration3/5
Registered within 30 days of the study start
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A medium-sized study: 500 participants (target), run at 21 sites.
How this score is built
- Enrolment26/40
500 participants (target)
- Site count4/25
2 sites
- Country count0/15
Single country
- Planned duration7/10
Planned over about 22 months
- Sponsor scale1/10
Claris Biotherapeutics, Inc. has led 3 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Résumé
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
Affections
- Limbal Stem Cell Deficiency
Éligibilité
| Sexe | Tous |
|---|---|
| Âges | 12 Years – 99 Years |
| Volontaires sains | Non |
| Méthode d'échantillonnage | PROBABILITY_SAMPLE |
Population de l'étude
Adult and adolescent subjects with qualifying LSCD
Éligibilité telle qu'elle figure dans le registre
Éligibilité en énoncés simples
Les critères de cette fiche n'ont pas encore été décomposés en énoncés distincts. Le texte du registre ci-dessus est complet et fait foi.
Conception de l'étude
| Type d'étude | Observationnelle |
|---|---|
| Phase | Non précisé dans la fiche du registre |
| Répartition | Non précisé dans la fiche du registre |
| Modèle d'intervention | Non précisé dans la fiche du registre |
| Objectif principal | Non précisé dans la fiche du registre |
| Insu | Non précisé dans la fiche du registre |
| Recrutement | 500 participants recherchés |
Promoteur et collaborateurs
- Claris Biotherapeutics, Inc. Promoteur
Groupes et interventions
- Non-interventional
No product administration.
Interventions
- Autre Non-interventional
Non-interventional
Critères de jugement
Critère de jugement principal
Natural Progression of LSCD as Assessed by Changes in Patient Reported Outcomes
Onset or changes (worsening or improving) in vision-related quality of life and ocular symptoms as captured with the National Eye Institute Visual Function Questionnaire-25 (VFQ-25) and Ocular Surface Disease Index (OSDI) questionnaires
Délai Screening through Week 84
Critère de jugement principal
Natural Progression of LSCD as Assessed by Functional Changes (Photophobic BCVA)
Change in photophobic BCVA
Délai Screening through Week 84
Critère de jugement principal
Natural Progression of LSCD as Assessed by Functional Changes (Low-luminance BCVA)
Change in low-luminance BCVA
Délai Screening through Week 84
Critère de jugement principal
Natural Progression of LSCD as Assessed by Functional Changes (Low-contrast BCVA)
Change in low-contrast BCVA
Délai Screening through Week 84
Critère de jugement principal
Natural Progression of LSCD as Assessed by Functional Changes (Contrast Sensitivity)
Change in contrast sensitivity (Pelli-Robson)
Délai Screening through Week 84
Critère de jugement principal
Natural Progression of LSCD as Assessed by Anatomical/Structural Changes
Change in area of central cornea conjunctivalization
Délai Screening through Week 84
Critère de jugement secondaire
Changes that May be Correlated with LSCD as Assessed by Functional Changes (Corneal Sensitivity)
Changes (onset, improvement, or worsening) in corneal sensitivity
Délai Screening through Week 84
Critère de jugement secondaire
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Corneal Topography/Tomography)
Changes (onset, improvement, or worsening) in corneal topography and/or tomography and/or densitometry
Délai Screening through Week 84
Critère de jugement secondaire
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Epithelial Defect Frequency)
Changes (onset, improvement, or worsening) in epithelial defect frequency
Délai Screening through Week 84
Critère de jugement secondaire
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Palisades of Vogt Crypts)
Changes (onset, improvement, or worsening) in Palisades of Vogt crypts
Délai Screening through Week 84
Critère de jugement secondaire
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Epithelial and Total Corneal Thickness)
Changes (onset, improvement, or worsening) in epithelial and total corneal thickness
Délai Screening through Week 84
Critère de jugement secondaire
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Pannus)
Changes (onset, improvement, or worsening) in pannus
Délai Screening through Week 84
Critère de jugement secondaire
Changes that May be Correlated with LSCD as Assessed by Changes Ocular and Systemic Health Outcome Measures
Changes (onset, improvement/resolution, or worsening) of an existing condition
Délai Screening through Week 84
Dates
| Date de début | 22 mai 2026 (réelle) |
|---|---|
| Achèvement principal | 1 mars 2028 (estimée) |
| Achèvement | 1 mars 2028 (estimée) |
| Première publication | 9 juin 2026 (réelle) |
| Dernière mise à jour | 18 novembre 2026 |
| Résultats publiés | Non précisé dans la fiche du registre |
| Statut vérifié pour la dernière fois | novembre 2026 |
Réelle signifie que l'événement a eu lieu. Estimée signifie que le promoteur s'y attend. Les deux ont un sens différent.
Lieux
21 sites sont en recrutement
United States
| Établissement | Ville | État ou région | Statut |
|---|---|---|---|
| Claris Investigative Site | Carmel | Indiana | En recrutement |
| Claris Investigative Site | Cranberry Township | Pennsylvania | En recrutement |
| Claris Investigative Site | Draper | Utah | En recrutement |
| Claris Investigative Site | Huntington Beach | California | En recrutement |
| Claris Investigative Site | Indianapolis | Indiana | En recrutement |
| Claris Investigative Site | Kansas City | Missouri | En recrutement |
| Claris Investigative Site | La Jolla | California | En recrutement |
| Claris Investigative Site | Los Angeles | California | En recrutement |
| Claris Investigative Site | Louisville | Kentucky | En recrutement |
| Claris Investigative Site | Minnetonka | Minnesota | En recrutement |
| Claris Investigative Site | Norfolk | Virginia | En recrutement |
| Claris Investigative Site | Overland Park | Kansas | En recrutement |
| Claris Investigative Site | Palisades Park | New Jersey | En recrutement |
| Claris Investigative Site | Portland | Oregon | En recrutement |
| Claris Investigative Site | Rockville Centre | New York | En recrutement |
| Claris Investigative Site | San Antonio | Texas | En recrutement |
| Claris Investigative Site | Sioux Falls | South Dakota | En recrutement |
| Claris Investigative Site | Smyrna | Tennessee | En recrutement |
| Claris Investigative Site | South Dartmouth | Massachusetts | En recrutement |
| Claris Investigative Site | Tampa | Florida | En recrutement |
| Claris Investigative Site | Wichita | Kansas | En recrutement |
Documents de l'étude
Aucun document n'est lié dans cette fiche du registre.
Évolution au fil du temps
- 18 novembre 2026
Site ajouté
13 sites added (21 total)
821
- 6 août 2026
Site ajouté
6 sites added (8 total)
28